Press release
Apixaban Market Size Forecasted To Achieve $4.48 Billion By 2029 With Steady Growth
Apixaban Market Size
What Is the Apixaban Market Size and Projected Growth Rate?
The apixaban market has seen steady expansion, predicted to increase from $2.92 billion in 2024 to $3.19 billion in 2025 at a CAGR of 9.2%. Growth factors include rising atrial fibrillation cases, an aging global population, regulatory green lights, favorable clinical trial outcomes, and a shift from warfarin to newer oral anticoagulants.
The apixaban market is forecast to grow to $4.48 billion in 2029 at a CAGR of 8.8%, driven by cardiovascular disease trends, improved diagnosis, and aging populations, with trends including telemedicine, drug innovation, and FDA approvals.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15979
What Are the Major Segments in the Apixaban Market?
The apixaban market covered in this report is segmented -
1) By Dosage Form: Capsule, Tablets
2) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Capsule: 2.5 mg Capsule, 5 mg Capsule
2) By Tablets: 2.5 mg Tablet, 5 mg Tablet
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15979&type=smp
What Are The Driving Apixaban Market Evolution?
The apixaban market is projected to grow due to the rising prevalence of cardiovascular diseases, which include heart failure, strokes, and coronary artery disease. These are largely driven by aging populations, high blood pressure, obesity, and sedentary lifestyles. Apixaban reduces blood clot risks in such conditions. The American Heart Association stated in January 2024 that cardiovascular disease deaths increased to 931,578 from 928,741 the year prior, reinforcing the market's expansion.
Which Firms Dominate The Apixaban Market Segments?
Major companies operating in the apixaban market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Fresenius Kabi AG, Hetero Drugs Ltd, Eisai Co. Ltd, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd, Medichem S.A., Centaur Pharmaceuticals Pvt. Ltd., Simson Pharma Limited, OPOCRIN SPA, Pinnacle Life Sciences Private Limited
What Apixaban Market Trends Are Gaining Traction Across Different Segments?
Companies in the apixaban market are developing generic anticoagulant drugs to improve accessibility and affordability while increasing their market presence. For example, Tiefenbacher Pharmaceuticals launched a generic version of Apixaban in Canada in October 2022. The drug helps in preventing blood clots and treating cardiovascular disorders, and the company plans to expand its availability globally, starting with Canada. This move offers cost savings for healthcare systems and increases patient access to essential treatments.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/apixaban-global-market-report
Which Is The Largest Region In The Apixaban Market?
North America was the largest region in the apixaban market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apixaban market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Apixaban Market?
2. What is the CAGR expected in the Apixaban Market?
3. What Are the Key Innovations Transforming the Apixaban Industry?
4. Which Region Is Leading the Apixaban Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Apixaban Market Size Forecasted To Achieve $4.48 Billion By 2029 With Steady Growth here
News-ID: 4032137 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for Apixaban
Apixaban Market Analysis Current Landscape and Future Outlook
The Apixaban market is expected to grow at a CAGR of 6.2% between 2025 and 2035, driven by the rising prevalence of cardiovascular diseases, increasing awareness of stroke prevention, and the growing preference for direct oral anticoagulants (DOACs) over traditional blood thinners.
Apixaban Market Overview
Apixaban is a factor Xa inhibitor that is widely used for the prevention and treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and stroke…
Key Trend Reshaping the Apixaban Market in 2025: Rise Of Generic Apixaban Expand …
What market dynamics are playing a key role in accelerating the growth of the apixaban market?
The increase in cases of cardiovascular disease is anticipated to boost the expansion of the apixaban market. The term cardiovascular disease covers a variety of conditions that impact the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. The escalation in cardiovascular diseases can be attributed to inactive lifestyles, poor nutrition,…
Primary Catalyst Driving Apixaban Market Evolution in 2025: Impact Of Cardiovasc …
What Is the Future Outlook for the Apixaban Market's Size and Growth Rate?
In the past few years, there has been significant growth in the apixaban market size. It is projected to ascend from $2.92 billion in 2024 to $3.19 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historic period is due to factors such as the rising case of atrial fibrillation,…
Apixaban Prices Surge Amid Increased Demand for Anticoagulant Medications
𝐊𝐨𝐫𝐞𝐚 𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐌𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐐𝟏
𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐢𝐧 𝐊𝐨𝐫𝐞𝐚:
As for apixaban, by March 2024, the prices available in South Korea was 43,000 USD/Ton The price during the first quarter was much the same as had been observed in the last quarter for all practical purposes, with little variation from changes in demand and production dynamics. The usage of widely prescribed blood-thinning medication apixaban maintained steady demand from health care…
Apixaban Market: Growth Dynamics, Trends, and Opportunities
Apixaban, an oral anticoagulant primarily used to prevent and treat blood clots, has become a cornerstone in modern medical practice. As an integral part of managing cardiovascular and thromboembolic disorders, its role in healthcare continues to expand. This article delves into the Apixaban market, covering its size, evolution, trends, growth drivers, and the increasing demand propelling its trajectory.
Market Size
Data Bridge Market Research analyses a growth rate in the global apixaban…
Apixaban Market Overview, Trends And Forecast 2024-2033
The new report published by The Business Research Company, titled ""Apixaban Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the apixaban market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to…
